| Language | English |
|---|---|
| Pages | 2302-2303 |
| Number of pages | 2 |
| Journal | Annals of oncology : official journal of the European Society for Medical Oncology |
| Volume | 27 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 1 Dec 2016 |
| Externally published | Yes |
Cite this
}
Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours : updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). / Lawrence, N.; Martin, A.; Toner, G.; Stockler, M.; Buizen, L.; Thomson, D.; Gebski, V.; Friedlander, M.; Yeung, A.; Wong, N.; Gurney, H.; Rosenthal, M.; Singhal, N.; Kichenadasse, G.; Wong, S.; Lewis, C.; Vasey, P.; Grimison, P.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 27, No. 12, 01.12.2016, p. 2302-2303.Research output: Contribution to journal › Letter › Research › peer-review
TY - JOUR
T1 - Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours
T2 - Annals of Oncology
AU - Lawrence, N.
AU - Martin, A.
AU - Toner, G.
AU - Stockler, M.
AU - Buizen, L.
AU - Thomson, D.
AU - Gebski, V.
AU - Friedlander, M.
AU - Yeung, A.
AU - Wong, N.
AU - Gurney, H.
AU - Rosenthal, M.
AU - Singhal, N.
AU - Kichenadasse, G.
AU - Wong, S.
AU - Lewis, C.
AU - Vasey, P.
AU - Grimison, P.
PY - 2016/12/1
Y1 - 2016/12/1
UR - http://www.scopus.com/inward/record.url?scp=85040925777&partnerID=8YFLogxK
U2 - 10.1093/annonc/mdw313
DO - 10.1093/annonc/mdw313
M3 - Letter
VL - 27
SP - 2302
EP - 2303
JO - Annals of Oncology
JF - Annals of Oncology
SN - 0923-7534
IS - 12
ER -